{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:51:34Z","timestamp":1792986694351,"version":"4.5.0"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Diabetic nephropathy (DN) has become the primary cause of end-stage renal disease globally, and its epidemiological burden intensifies alongside the surging prevalence of diabetes. The pathogenesis involves complex interactions among metabolic dysregulation, oxidative stress, inflammatory responses, and fibrotic signaling pathways. Hyperglycemia drives renal injury through activation of the RAAS and accumulation of advanced glycation end products (AGEs), while aberrant activation of key signaling pathways such as TGF-\u03b2\/Smad3 and NF-\u03baB further promotes renal fibrosis. Current clinical diagnosis primarily relies on proteinuria and glomerular filtration rate indicators, yet their insufficient sensitivity for early renal injury leads to high underdiagnosis rates of nonproteinuric DN. Traditional therapy, centered on renin-angiotensin system blockers, can delay disease progression but fails to reverse renal fibrosis. Recent years have witnessed significant therapeutic breakthroughs. These include SGLT2 inhibitors improving glomerular hypertension via mechanisms independent of glucose-lowering, novel anti-inflammatory and anti-fibrotic agents such as nonsteroidal mineralocorticoid receptor antagonists targeting TGF-\u03b2\/Smad3 pathway inhibition, and multi-target traditional Chinese medicine interventions offering comprehensive protection by regulating signaling networks like PI3K\/Akt and AGE-RAGE. At the molecular level, research reveals that inflammation and immune dysregulation, oxidative stress and metabolic disorders, epigenetic modifications, and cellular structural and functional damage collectively form the intricate pathological network of diabetic nephropathy. Emerging technologies like nanodrug delivery systems, stem cell therapy, and gene editing show broad prospects for precise interventions targeting specific molecular pathways. Future research must integrate multi-omics technologies to deeply dissect disease heterogeneity, develop efficient biomarkers for early diagnosis, and optimize therapeutic efficacy through innovative drug delivery systems, while strengthening evidence-based validation of integrated traditional Chinese and Western medicine strategies. This approach will provide novel insights for the precise prevention and control of diabetic nephropathy.<\/jats:p>","DOI":"10.3389\/fphar.2025.1729941","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:45:43Z","timestamp":1766040343000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Molecular mechanisms and multi-target therapeutic strategies of diabetic nephropathy: from pathogenesis to precision interventions"],"prefix":"10.3389","volume":"16","author":[{"given":"Jiahuan","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangdong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e19325","DOI":"10.7759\/cureus.19325","article-title":"Endothelin receptor antagonists as a potential treatment of diabetic nephropathy: a systematic review","volume":"13","author":"Ahmad","year":"2021","journal-title":"Cureus"},{"key":"B2","doi-asserted-by":"publisher","first-page":"30139","DOI":"10.1021\/acsomega.3c02621","article-title":"The effect of olive waste on the rheological properties, thickening time, permeability, and strength of oil well cement","volume":"8","author":"Ali","year":"2023","journal-title":"ACS Omega"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2945234","DOI":"10.1155\/2023\/2945234","article-title":"Combination of Astragalus membranaceus and Panax notoginseng as main components in the treatment of diabetic nephropathy: a systematic review and meta-analysis","volume":"2023","author":"An","year":"2023","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2174\/1566524023666230727093911","article-title":"A narrative review of signaling pathway and treatment options for diabetic nephropathy","volume":"25","author":"Bhupesh","year":"2025","journal-title":"Curr. Mol. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1080\/07448481.2022.2133567","article-title":"Gendered racial microaggressions and black college women: a cross-sectional study of depression and psychological distress","volume":"72","author":"Burton","year":"2024","journal-title":"J. Am. Coll. Health"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s00592-021-01766-y","article-title":"TIMP3 involvement and potentiality in the diagnosis, prognosis and treatment of diabetic nephropathy","volume":"58","author":"Casagrande","year":"2021","journal-title":"Acta Diabetol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"111726","DOI":"10.1016\/j.diabres.2024.111726","article-title":"Molecular mechanisms of gut microbiota in diabetic nephropathy","volume":"213","author":"Cheng","year":"2024","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B8","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/978-981-15-4272-5_36","article-title":"Autophagy and diabetic nephropathy","volume":"1207","author":"Cui","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12911-023-02380-4","article-title":"Data-driven meal events detection using blood glucose response patterns","volume":"23","author":"D","year":"2023","journal-title":"BMC Med. Inf. Decis. Mak."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e28747","DOI":"10.1097\/MD.0000000000028747","article-title":"Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy","volume":"101","author":"Dai","year":"2022","journal-title":"Med. Baltim."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1290868","DOI":"10.3389\/fphar.2023.1290868","article-title":"Identification of the main flavonoids of Abelmoschus manihot (L.) medik and their metabolites in the treatment of diabetic nephropathy","volume":"14","author":"Diao","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1383203","DOI":"10.3389\/fphar.2024.1383203","article-title":"Ferroptosis and the ubiquitin-proteasome system: exploring treatment targets","volume":"15","author":"Din","year":"2024","journal-title":"Cancer. Front. in Pharmacology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"9420010","DOI":"10.26599\/fmh.2024.9420010","article-title":"A novel antidiabetic peptide GPAGAP from Andrias davidianus collagen hydrolysates: screening, action mechanism prediction and improving insulin resistance in HepG2 cells","volume":"1","author":"Dong","year":"2024","journal-title":"Food & Med. Homol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1055\/a-2435-8264","article-title":"Diabetic nephropathy: pathogenesis, mechanisms, and therapeutic strategies","volume":"57","author":"Dwivedi","year":"2024","journal-title":"Horm. Metab. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e35397","DOI":"10.1097\/MD.0000000000035397","article-title":"Comprehensive advancements in the prevention and treatment of diabetic nephropathy: a narrative review","volume":"102","author":"Elendu","year":"2023","journal-title":"Med. Baltim."},{"key":"B16","doi-asserted-by":"publisher","first-page":"18037","DOI":"10.1021\/acsnano.3c04671","article-title":"Enhanced biohomogeneous composite membrane-encapsulated nanoplatform with podocyte targeting for precise and safe treatment of diabetic nephropathy","volume":"17","author":"Fan","year":"2023","journal-title":"ACS Nano"},{"key":"B17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12906-022-03662-6","article-title":"Network pharmacology and molecular docking technology-based predictive study of the active ingredients and potential targets of rhubarb for the treatment of diabetic nephropathy","volume":"22","author":"Fu","year":"2022","journal-title":"BMC Complement. Med. Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.17219\/acem\/175776","article-title":"The roles of autophagy in the treatment of diabetic nephropathy with rapamycin","volume":"33","author":"Fu","year":"2024","journal-title":"Adv. Clin. Exp. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1438266","DOI":"10.3389\/fmed.2024.1438266","article-title":"Perspectives of clinical research on shen-shuai-ning in the treatment of diabetic nephropathy","volume":"11","author":"Gao","year":"2024","journal-title":"Front. Med. (Lausanne)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e32095","DOI":"10.1097\/MD.0000000000032095","article-title":"Xuebijing injection combined with alprostadil in the treatment of diabetic nephropathy: a PRISMA-compliant systematic review and meta-analysis","volume":"103","author":"Hao","year":"2024","journal-title":"Med. Baltim."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.jconrel.2022.06.029","article-title":"Nanodisc delivery of liver X receptor agonist for the treatment of diabetic nephropathy","volume":"348","author":"He","year":"2022","journal-title":"J. Control Release"},{"key":"B22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2174\/1871530323666230915100355","article-title":"The mechanism of plantaginis semen in the treatment of diabetic nephropathy based on network pharmacology and molecular docking technology","volume":"24","author":"He","year":"","journal-title":"Endocr. Metabolic & Immune Disorders Drug Targets"},{"key":"B23","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7150\/ijbs.87820","article-title":"Treatment for type 2 diabetes and diabetic nephropathy by targeting Smad3 signaling","volume":"20","author":"He","year":"","journal-title":"Int. J. Biol. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"23259671241256983","DOI":"10.1177\/23259671241256983","article-title":"Comparison of clinical outcomes after medial patellofemoral ligament reconstruction with allograft Versus autograft: a matched-cohort analysis","volume":"12","author":"Henstenburg","year":"2024","journal-title":"Orthop. J. Sports Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1098136","DOI":"10.3389\/fphar.2022.1098136","article-title":"Construction of a ferroptosis scoring system and identification of LINC01572 as a novel ferroptosis suppressor in lung adenocarcinoma","volume":"13","author":"Hong","year":"2022","journal-title":"Front. Pharmacology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-025-01587-4","article-title":"AARS1-mediated lactylation of H3K18 and STAT1 promotes ferroptosis in diabetic nephropathy","author":"Hong","year":"2025","journal-title":"Cell Death Differ."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0265642","DOI":"10.1371\/journal.pone.0265642","article-title":"Efficacy and safety of eplerenone treatment for patients with diabetic nephropathy: a meta-analysis","volume":"17","author":"Hu","year":"","journal-title":"PLoS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"943","DOI":"10.2147\/DMSO.S350062","article-title":"Potential molecular mechanism of Yishen capsule in the treatment of Diabetic nephropathy based on network pharmacology and molecular docking","volume":"15","author":"Hu","year":"","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e202319780","DOI":"10.1002\/anie.202319780","article-title":"A tandem-locked chemiluminescent probe for imaging of tumor-associated macrophage polarization","volume":"63","author":"Huang","year":"2024","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"B30","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/ndt\/gfab330","article-title":"Regression of diabetic nephropathy by treatment with empagliflozin in BTBR ob\/ob mice","volume":"37","author":"Hudkins","year":"2022","journal-title":"Nephrol. Dial. Transpl."},{"key":"B31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000522013","article-title":"Effects of L-Carnitine treatment on kidney Mitochondria and macrophages in mice with diabetic nephropathy","volume":"47","author":"Ito","year":"2022","journal-title":"Kidney Blood Press Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"10595","DOI":"10.26355\/eurrev_202311_34339","article-title":"Statin therapy for patients with diabetic nephropathy: balance between safety and efficacy of statin treatment for patients with impaired kidney function","volume":"27","author":"Jairoun","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"275","DOI":"10.4314\/tjpr.v20i2.8","article-title":"Protective effect of syringaresinol on rats with diabetic nephropathy via regulation of Nrf2\/HO-1 and TGF-\u03b21\/Smads pathways","volume":"20","author":"Ji","year":"2021","journal-title":"Trop. J. Pharm. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/14728214.2022.2155632","article-title":"Emerging drugs for the treatment of diabetic nephropathy","volume":"27","author":"Kim","year":"2022","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"B35","doi-asserted-by":"publisher","first-page":"995","DOI":"10.3390\/jcm13040995","article-title":"The role of angiotensin-converting enzyme (ACE) polymorphisms in the risk of development and treatment of diabetic nephropathy","volume":"13","author":"Kr\u00f3l-Kulikowska","year":"2024","journal-title":"J. Clin. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"145532","DOI":"10.1016\/j.gene.2021.145532","article-title":"An updated pharmacological insight of resveratrol in the treatment of diabetic nephropathy","volume":"780","author":"Li","year":"2021","journal-title":"Gene"},{"key":"B37","doi-asserted-by":"publisher","first-page":"154348","DOI":"10.1016\/j.phymed.2022.154348","article-title":"Effective dose\/duration of natural flavonoid quercetin for treatment of diabetic nephropathy: a systematic review and meta-analysis of rodent data","volume":"105","author":"Li","year":"2022","journal-title":"Phytomedicine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3892\/etm.2020.9446","article-title":"Short- and long-term treatment with angiotensin-converting enzyme inhibitors or calcium channel blockers for the prevention of diabetic nephropathy progression: a meta-analysis","volume":"21","author":"Liang","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2359033","DOI":"10.1080\/0886022X.2024.2359033","article-title":"Efficacy of astragalus combined with renin-angiotensin-aldosterone system blockers in the treatment of stage III diabetic nephropathy: a systematic review and meta-analysis","volume":"46","author":"Lin","year":"2024","journal-title":"Ren. Fail"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1142\/S0192415X22500744","article-title":"A review of traditional Chinese medicine on treatment of diabetic nephropathy and the involved mechanisms","volume":"50","author":"Liu","year":"","journal-title":"Am. J. Chin. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"154079","DOI":"10.1016\/j.phymed.2022.154079","article-title":"Efficacy and safety of Zicuiyin decoction on diabetic kidney disease: a multicenter, randomized controlled trial","volume":"100","author":"Liu","year":"","journal-title":"Phytomedicine"},{"key":"B42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13643-025-02872-6","article-title":"Efficacy and incidence of complications of hemodialysis in the treatment of diabetic nephropathy: a systematic review and meta-analysis","volume":"14","author":"Liu","year":"2025","journal-title":"Syst. Rev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2133705","DOI":"10.1155\/2022\/2133705","article-title":"Efficacy and safety of zhenwu decoction in the treatment of diabetic nephropathy: a systematic review and meta-analysis","volume":"2022","author":"Lv","year":"2022","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"110701","DOI":"10.1016\/j.cbi.2023.110701","article-title":"Ferroptosis contributes to cyclophosphamide-induced hemorrhagic cystitis","volume":"384","author":"Mao","year":"2023","journal-title":"Chemico-biological Interactions"},{"key":"B45","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1111\/dom.15832","article-title":"Cost-effectiveness of sodium-glucose cotransporter-2 inhibitors in the treatment of diabetic nephropathy in Japan","volume":"26","author":"Maruyama-Sakurai","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"B46","doi-asserted-by":"publisher","first-page":"982","DOI":"10.34067\/kid.0002352020","article-title":"Shaping up mitochondria in diabetic nephropathy","volume":"1","author":"Mise","year":"2020","journal-title":"Kidney360"},{"key":"B47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4239\/wjd.v13.i3.150","article-title":"Efficacy of probiotics on the modulation of gut microbiota in the treatment of diabetic nephropathy","volume":"13","author":"Nagase","year":"2022","journal-title":"World J. Diabetes"},{"key":"B48","doi-asserted-by":"publisher","first-page":"115283","DOI":"10.1016\/j.jep.2022.115283","article-title":"The therapeutic mechanism of PuRenDan for the treatment of diabetic nephropathy: network pharmacology and experimental verification","volume":"293","author":"Niu","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"813012","DOI":"10.3389\/fphys.2021.813012","article-title":"Stimulation of angiotensin converting enzyme 2: a novel treatment strategy for diabetic nephropathy","volume":"12","author":"Nomura","year":"2021","journal-title":"Front. Physiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e33235","DOI":"10.7759\/cureus.33235","article-title":"A narrative review of new treatment options for diabetic nephropathy","volume":"15","author":"Pillai","year":"2023","journal-title":"Cureus"},{"key":"B51","doi-asserted-by":"publisher","first-page":"7845848","DOI":"10.1155\/2021\/7845848","article-title":"Tibetan medicines for the treatment of diabetic nephropathy","volume":"2021","author":"Pu","year":"2021","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"173503","DOI":"10.1016\/j.ejphar.2020.173503","article-title":"Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: preclinical evidences with therapeutic approaches","volume":"885","author":"Ram","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1497449","DOI":"10.1155\/2021\/1497449","article-title":"Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment","volume":"2021","author":"Samsu","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"B54","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.21037\/apm-20-1799","article-title":"Efficacy and safety of Bailing capsules in the treatment of type 2 diabetic nephropathy: a meta-analysis","volume":"9","author":"Sheng","year":"2020","journal-title":"Ann. Palliat. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"16058","DOI":"10.1039\/d4nr02010c","article-title":"Restoring physiological parameters of the pancreas and kidney through treatment with a polymeric nano-formulation of C-peptide and lisofylline combination in diabetic nephropathy","volume":"16","author":"Singh","year":"2024","journal-title":"Nanoscale"},{"key":"B56","doi-asserted-by":"publisher","first-page":"119762","DOI":"10.1016\/j.cca.2024.119762","article-title":"Urinary biomarkers in diabetic nephropathy","volume":"561","author":"Soltani-Fard","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"B57","doi-asserted-by":"publisher","first-page":"114699","DOI":"10.1016\/j.jep.2021.114699","article-title":"Integrated lipidomics, transcriptomics and network pharmacology analysis to reveal the mechanisms of Danggui Buxue decoction in the treatment of diabetic nephropathy in type 2 diabetes mellitus","volume":"283","author":"Sun","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"116858","DOI":"10.1016\/j.biopha.2024.116858","article-title":"AKAP1 alleviates VSMC phenotypic modulation and neointima formation by inhibiting Drp1-dependent mitochondrial fission","volume":"176","author":"Sun","year":"2024","journal-title":"Biomed. & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1296843","DOI":"10.3389\/fendo.2024.1296843","article-title":"Research progress on the treatment of diabetic nephropathy with leech and its active ingredients","volume":"15","author":"Tian","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"113524","DOI":"10.1016\/j.biopha.2022.113524","article-title":"Ferroptosis in colorectal cancer: potential mechanisms and effective therapeutic targets","volume":"153","author":"Wang","year":"2022","journal-title":"Biomed. & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.14670\/HH-18-599","article-title":"Treatment of berberine alleviates diabetic nephropathy by reducing iron overload and inhibiting oxidative stress","volume":"38","author":"Wang","year":"2023","journal-title":"Histol. Histopathol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1489956","DOI":"10.3389\/fphar.2024.1489956","article-title":"Isatin improves oligoasthenospermia caused by busulfan by regulating GSH\/GPX4 axis to inhibit ferroptosis","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1621968","DOI":"10.3389\/fendo.2025.1621968","article-title":"Targeting gut microbiota for diabetic nephropathy treatment: probiotics, dietary interventions, and fecal microbiota transplantation","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1188003","DOI":"10.3389\/fendo.2023.1188003","article-title":"Ferroptosis: a new strategy for Chinese herbal medicine treatment of diabetic nephropathy","volume":"14","author":"Wei","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1207777","DOI":"10.3389\/fphar.2023.1207777","article-title":"Research progress on Cornus officinalis and its active compounds in the treatment of diabetic nephropathy","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B66","first-page":"1187","article-title":"Effect of hyperbaric oxygen combined with alprostadil in the treatment of elderly diabetic nephropathy and effects on serum miR-126 and miR-342 levels","volume":"34","author":"Xi","year":"2021","journal-title":"Pak J. Pharm. Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"015013","DOI":"10.1117\/1.NPh.12.1.015013","article-title":"Optical attenuation coefficient decorrelation-based optical coherence tomography angiography for microvascular evaluation of Alzheimer's disease on mice","volume":"12","author":"Xiang","year":"2025","journal-title":"Neurophotonics"},{"key":"B68","doi-asserted-by":"publisher","first-page":"28283","DOI":"10.31083\/FBL28283","article-title":"The potential and challenges of human pluripotent stem cells in the treatment of diabetic nephropathy","volume":"30","author":"Xu","year":"2025","journal-title":"Front. Biosci. Landmark Ed."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e2414587","DOI":"10.1002\/advs.202414587","article-title":"Isoquercitrin alleviates diabetic nephropathy by inhibiting STAT3 phosphorylation and dimerization","volume":"12","author":"Xuan","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"B70","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.2147\/DMSO.S471940","article-title":"Network pharmacology and experimental analysis to explore the effect and mechanism of modified Buyang Huanwu decoction in the treatment of diabetic nephropathy","volume":"17","author":"Yang","year":"2024","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"B71","doi-asserted-by":"publisher","first-page":"121057","DOI":"10.1016\/j.envres.2025.121057","article-title":"Parents greater influenced the fecal microbiome and resistome of ibis nestlings than artifical breeding environment contamination","volume":"271","author":"Yang","year":"2025","journal-title":"Environ. Research"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e36438","DOI":"10.7759\/cureus.36438","article-title":"An investigation on the efficacy of glucagon-like peptide 1 receptor agonists drugs in reducing urine albumin-to-creatinine ratio in patients with type 2 diabetes: a potential treatment for diabetic nephropathy","volume":"15","author":"Yarlagadda","year":"2023","journal-title":"Cureus"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1681\/ASN.2020081188","article-title":"Pre-emptive short-term nicotinamide mononucleotide treatment in a mouse model of diabetic nephropathy","volume":"32","author":"Yasuda","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"115899","DOI":"10.1016\/j.biopha.2023.115899","article-title":"Effects of total flavones of Abelmoschus manihot (L.) on the treatment of diabetic nephropathy via the activation of solute carriers in renal tubular epithelial cells","volume":"169","author":"Yu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B75","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41401-023-01144-0","article-title":"SGLT2 inhibitor empagliflozin alleviates cardiac remodeling and contractile anomalies in a FUNDC1-dependent manner in experimental Parkinson's disease","volume":"45","author":"Yu","year":"","journal-title":"Acta Pharmacologica Sin."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1424968","DOI":"10.3389\/fphar.2024.1424968","article-title":"Effects of Abelmoschus manihot (L.) and its combination with irbesartan in the treatment of diabetic nephropathy via the gut-kidney axis","volume":"15","author":"Yu","year":"","journal-title":"Front. Pharmacol."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2022.1.06","article-title":"The efficacy and safety of canagliflozin in the treatment of patients with early diabetic nephropathy","volume":"73","author":"Zhang","year":"2022","journal-title":"J. Physiol. Pharmacol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"131898","DOI":"10.1016\/j.ijbiomac.2024.131898","article-title":"Discovery of a SUCNR1 antagonist for potential treatment of diabetic nephropathy: in silico and in vitro studies","volume":"268","author":"Zhang","year":"","journal-title":"Int. J. Biol. Macromol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jconrel.2024.06.049","article-title":"A glycopolymersome strategy for 'drug-free' treatment of diabetic nephropathy","volume":"372","author":"Zhang","year":"","journal-title":"J. Control Release"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.fshw.2023.02.023","article-title":"Alleviating effects and mechanisms of action of large-leaf yellow tea drinking on diabetes and diabetic nephropathy in mice","volume":"12","author":"Zhao","year":"2023","journal-title":"Food Sci. Hum. Wellness"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1327030","DOI":"10.3389\/fphar.2024.1327030","article-title":"Efficacy and safety of traditional Chinese medicine decoction as an adjuvant treatment for diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Zheng","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1354950","DOI":"10.3389\/fendo.2024.1354950","article-title":"Network pharmacology combined with Mendelian randomization analysis to identify the key targets of renin-angiotensin-aldosterone system inhibitors in the treatment of diabetic nephropathy","volume":"15","author":"Zhou","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B83","doi-asserted-by":"publisher","first-page":"107660","DOI":"10.1016\/j.intimp.2021.107660","article-title":"Alpinetin exerts anti-inflammatory, anti-oxidative and anti-angiogenic effects through activating the Nrf2 pathway and inhibiting NLRP3 pathway in carbon tetrachloride-induced liver fibrosis","volume":"96","author":"Zhu","year":"2021","journal-title":"Int. Immunopharmacology"},{"key":"B84","doi-asserted-by":"publisher","first-page":"9651","DOI":"10.3390\/ijms25179651","article-title":"Repurposing Niclosamide to modulate renal RNA-binding protein HuR for the treatment of diabetic nephropathy in db\/db mice","volume":"25","author":"Zhuang","year":"2024","journal-title":"Int. J. Mol. Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1729941\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:45:44Z","timestamp":1766040344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1729941\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":84,"alternative-id":["10.3389\/fphar.2025.1729941"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1729941","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"article-number":"1729941"}}